eli lilly retatrutide trials Lilly's tirzepatide showed positive results in late-stage trial as treatment for heart failure Eli Lilly's Retatrutide Delivers Bariatric-Style

These patents were originally filed as an international application on March 20, 2006

Scale of projections: Estimates for Wegovy, Mounjaro, and Zepbound are based on Wall Street consensus projections, underscoring investor expectations for explosive growth and demand in the GLP-1 market

Current Availability and Regulatory Status in the UK Retatrutide is not approved for clinical use in the UK as of April 2025 and can only be accessed through MHRA-registered clinical trials

We synthesize every batch using high-fidelity, automated Solid-Phase Peptide Synthesis (SPPS)

The problem

Cost savings: Maintenance doses can reduce annual spending by 50-70%